視網(wǎng)膜劈裂蛋白(RS)重組蛋白
Recombinant Retinoschisin (RS)
RS1; XLRS1; Retinoschisis X-Linked,Juvenile 1; X-linked juvenile retinoschisis protein
- 編號RPJ847Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量53.0kDa
- 實際分子量53kDa(差異分析請參閱說明書)
- 片段與標簽Ser24~Ala224 with N-terminal His and GST Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點5.5
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 960¥ 2400¥ 4800¥ 14400¥ 36000
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPJ847Hu01 | 視網(wǎng)膜劈裂蛋白(RS)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ847Hu01 | 視網(wǎng)膜劈裂蛋白(RS)多克隆抗體 | WB |
| MAJ847Hu21 | 視網(wǎng)膜劈裂蛋白(RS)單克隆抗體 | WB; IHC; ICC; IP. |
| SEJ847Hu | 視網(wǎng)膜劈裂蛋白(RS)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCJ847Hu | 視網(wǎng)膜劈裂蛋白(RS)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMJ847Hu | 視網(wǎng)膜劈裂蛋白(RS)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Hum Gene Ther | Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis.[PubMed: 22295905] |
| IEEE Transactions on Magnetics | Influence of Iron Oxide Nanoparticles on Innate and Genetically Modified Secretion Profiles of Mesenchymal Stem Cells[Scholarsportal: Source] |
| International Journal of Pharmaceutics | A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases[Pubmed:24576595] |
| 22 | Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles[Pubmed:26986855] |
| UBC Library | Cell based therapeutics for retinal degenerations[cIRcle:1.0303136] |
| Molecular Vision | An ex vivo gene therapy approach in X-linked retinoschisis[pubmed:27390514] |